Do you have the same question? Follow this Question
Feb 03, 2026 - 08:04 AM
We’ve provided several answers to questions related to Vitrakvi (Larotrectinib) , see some other helpful Q&A related to this product.
Question: Is larotrectinib chemo?
Answer: Larotrectinib is not considered traditional chemotherapy. It is a targeted therapy that specifically inhibits TRK fusion proteins found in certain cancers. Unlike chemotherapy, which affects many types of rapidly dividing cells, larotrectinib targets cancer cells with specific genetic mutations.
Question: What is the legal status of this medication?
Answer: This medication is available by prescription only. Prescription-only status ensures that the drug is used under medical supervision, which is important for safety, especially with cancer treatments.
Question: What is the typical adult dose for this medication?
Answer: The usual adult dose is 100 mg taken orally twice daily, but a doctor may adjust this as needed. This standard dosing regimen provides a consistent therapeutic effect and allows for modifications based on patient response or side effects.
